Showing results (511-520 of 544) with videos related to
Sort By:
Pageof 55
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trialM Annala, S Fu, J V W Bacon, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2024
Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140Nikola Zagorec, Alizée Calamel, Margaux Delaporte, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibitionCaroline P Kerr, Won Jong Jin, Peng Liu, et al.Human Molecular Genetics|January 11, 2007
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factorAsif Ali, Paul T Christie, Irina V Grigorieva, et al.Nature Communications|January 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in miceCaroline P Kerr, Won Jong Jin, Peng Liu, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2020
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi SurveyYeoungjee Cho, Gopala Rangan, Charlotte Logeman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 11, 2020
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus WorkshopYeoungjee Cho, Allison Tong, Jonathan C Craig, et al.Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.American Journal of Human Genetics|December 10, 2021
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotypeSarah R Senum, Ying Sabrina M Li, Katherine A Benson, et al.Pageof 55